Bin Xu

2.5k total citations
96 papers, 1.6k citations indexed

About

Bin Xu is a scholar working on Oncology, Epidemiology and Hepatology. According to data from OpenAlex, Bin Xu has authored 96 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 25 papers in Epidemiology and 22 papers in Hepatology. Recurrent topics in Bin Xu's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Bin Xu is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (11 papers) and Cancer Immunotherapy and Biomarkers (7 papers). Bin Xu collaborates with scholars based in China, Ethiopia and United States. Bin Xu's co-authors include Hui‐Chuan Sun, Liping Zhu, Jiqin Wu, Xueting Ou, Xinhua Weng, Xiao‐Dong Zhu, Qiwen Ben, Rui Chai, Aihua Qian and Yunwei Sun and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Nano Letters.

In The Last Decade

Bin Xu

89 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bin Xu China 24 449 402 385 289 180 96 1.6k
Yi‐Lin Chiu United States 21 313 0.7× 452 1.1× 1.0k 2.7× 317 1.1× 227 1.3× 102 2.6k
Deborah Rund Israel 27 322 0.7× 265 0.7× 597 1.6× 189 0.7× 170 0.9× 89 2.8k
Ingeborg A. Hauser Germany 25 540 1.2× 666 1.7× 296 0.8× 215 0.7× 380 2.1× 61 2.2k
Jiong Yu China 24 391 0.9× 278 0.7× 618 1.6× 837 2.9× 340 1.9× 76 2.2k
Dawei Wu China 26 351 0.8× 681 1.7× 527 1.4× 165 0.6× 486 2.7× 111 2.1k
Shuyun Wang China 19 297 0.7× 345 0.9× 398 1.0× 59 0.2× 130 0.7× 109 1.3k
Hui Guo China 22 219 0.5× 272 0.7× 677 1.8× 767 2.7× 221 1.2× 93 2.0k
Masahiro Ogawa Japan 22 813 1.8× 171 0.4× 516 1.3× 141 0.5× 223 1.2× 117 1.9k
Revital Kariv Israel 24 804 1.8× 475 1.2× 237 0.6× 151 0.5× 388 2.2× 90 1.9k

Countries citing papers authored by Bin Xu

Since Specialization
Citations

This map shows the geographic impact of Bin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bin Xu more than expected).

Fields of papers citing papers by Bin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bin Xu. The network helps show where Bin Xu may publish in the future.

Co-authorship network of co-authors of Bin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Bin Xu. A scholar is included among the top collaborators of Bin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bin Xu. Bin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
He, Haiyang, Liuyang Cai, Qin Huang, et al.. (2025). Disseminated talaromycosis in HIV-negative patients with lung cancer: a rare case report and literature review. BMC Infectious Diseases. 25(1). 601–601.
2.
3.
4.
Dong, Sheng-Yong, Wei‐Zen Sun, Bin Xu, et al.. (2023). Quantitative image features of gadoxetic acid-enhanced MRI for predicting glypican-3 expression of small hepatocellular carcinoma ≤3 cm. Clinical Radiology. 78(10). e764–e772. 1 indexed citations
5.
Liu, Xuefeng, Xiao‐Dong Zhu, Long-Hai Feng, et al.. (2022). Physical activity improves outcomes of combined lenvatinib plus anti-PD-1 therapy in unresectable hepatocellular carcinoma: a retrospective study and mouse model. Experimental Hematology and Oncology. 11(1). 20–20. 16 indexed citations
6.
Xu, Minghao, Bin Xu, Chenhao Zhou, et al.. (2022). An mALBI-Child–Pugh-based nomogram for predicting post-hepatectomy liver failure grade B–C in patients with huge hepatocellular carcinoma: a multi-institutional study. World Journal of Surgical Oncology. 20(1). 206–206. 5 indexed citations
7.
Chen, Qi, Qingqing Wang, Bin Xu, et al.. (2021). Cumulative effects of ambient particulate matter pollution on deaths: A multicity analysis of mortality displacement. Chemosphere. 286(Pt 1). 131615–131615. 7 indexed citations
8.
Wang, Jie, Yiqi Yu, Chao Qiu, et al.. (2020). Maternal antiviral treatment safeguards infants from hepatitis B transmission in contingencies of delayed immunoprophylaxis. Liver International. 40(10). 2377–2384. 2 indexed citations
9.
Li, Xiao‐Long, Xiao‐Dong Zhu, Xuefeng Liu, et al.. (2020). A prospective study of the effect of terlipressin on portal vein pressure and clinical outcomes after hepatectomy: A pilot study. Surgery. 167(6). 926–932. 8 indexed citations
10.
Han, Xu, Xuan Wang, Zhi Yu, & Bin Xu. (2020). Research progress on factors influencing streptozotocin-induced diabetic rat models. 28(5). 716–725. 2 indexed citations
11.
12.
Liu, Li, Caiyi Lu, Xi Chen, et al.. (2016). Electrophysiological Characteristics of the LQT2 Syndrome Mutation KCNH2-G572S and Regulation by Accessory Protein KCNE2. Frontiers in Physiology. 7. 650–650. 11 indexed citations
13.
Xu, Bin, Li Liu, Xiaojing Zhao, et al.. (2015). Effect ofα-Allocryptopine on Delayed Afterdepolarizations and Triggered Activities in Mice Cardiomyocytes Treated with Isoproterenol. Evidence-based Complementary and Alternative Medicine. 2015. 1–9. 4 indexed citations
14.
Ben, Qiwen, Yunwei Sun, Rui Chai, et al.. (2013). Dietary Fiber Intake Reduces Risk for Colorectal Adenoma: A Meta-analysis. Gastroenterology. 146(3). 689–699.e6. 121 indexed citations
15.
Zhu, Dexiang, Jie Wang, Li Ren, et al.. (2012). Serum proteomic profiling for the early diagnosis of colorectal cancer. Journal of Cellular Biochemistry. 114(2). 448–455. 23 indexed citations
16.
Zhu, Beibei, Weiguo Hu, Liming Cheng, et al.. (2012). A Common SMAD7 Variant Is Associated with Risk of Colorectal Cancer: Evidence from a Case-Control Study and a Meta-Analysis. PLoS ONE. 7(3). e33318–e33318. 18 indexed citations
17.
Wang, Hongjuan, Cong Ma, Jie Yang, et al.. (2012). CYP4F2 polymorphism as a genetic risk factor for major hemorrhagic complications in Chinese patients on warfarin therapy. Journal of Geriatric Cardiology. 9(2). 209–210. 4 indexed citations
18.
Xu, Bin, et al.. (2011). Combined CVVH-bilirubin adsorption therapy on patients with hyperbilirubinemia. 20(3). 204–211. 2 indexed citations
19.
Xu, Bin, et al.. (2010). The effect of Lasianthus fardii Hance on duck hepatitis B.. Xiandai yufang yixue. 37(14). 2710–2712. 1 indexed citations
20.
Xu, Bin. (2004). Effect of matrine on levels of TGF-β_1, TNF-α,HA and PcIII in sera of chronic hepatitis B patients. Zhongguo xiandai yixue/Zhongguo xiandai yixue zazhi. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yi‐Lin Chiu Breakdown of academic impact, for papers by Deborah Rund Breakdown of academic impact, for papers by Ingeborg A. Hauser Breakdown of academic impact, for papers by Jiong Yu Breakdown of academic impact, for papers by Dawei Wu Breakdown of academic impact, for papers by Shuyun Wang Breakdown of academic impact, for papers by Hui Guo Breakdown of academic impact, for papers by Masahiro Ogawa Breakdown of academic impact, for papers by Revital Kariv
Rankless by CCL
2026